SMS Pharmaceuticals Ltd Quarterly Results

Gross Sales

196.05

248.2

173.35

196.75

164.45

Excise Duty

0

0

0

0

0

Net Sales

196.05

248.2

173.35

196.75

164.45

Other Operating Income

0

0

0

0

0

Other Income

0.59

1.42

2.13

1.3

1.37

Total Income

196.64

249.62

175.48

198.05

165.82

Total Expenditure

156.68

207.39

140.14

165.28

130.94

PBIDT

39.96

42.23

35.34

32.77

34.88

Interest

5.84

5.07

4.2

4.61

4.67

PBDT

34.12

37.16

31.13

28.16

30.21

Depreciation

9.75

8.64

8.7

8.62

8.38

Minority Interest Before NP

0

0

0

0

0

Tax

5

4.65

4.99

4.7

5.3

Deferred Tax

0.65

3.79

0.37

0.98

0.16

Reported Profit After Tax

18.71

20.08

17.08

13.86

16.37

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

20.49

20.32

18.24

14.1

16.48

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

20.49

20.32

18.24

14.1

16.48

EPS (Unit Curr.)

2.31

2.4

2.15

1.67

1.95

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

8.87

8.87

8.47

8.47

8.47

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

20.38

17.01

20.38

16.65

21.21

PBDTM(%)

17.4

14.97

17.95

14.31

18.37

PATM(%)

9.54

8.09

9.85

7.04

9.95